About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Emsella for Reducing tSUI After HOLEP

NCT07580404·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Alyssa McDonald, MPH
CONTACT
312-695-8146 alyssa.mcdonald@northwestern.edu

Lead

Northwestern University

Age

50–80

Sex

MALE

Healthy volunteers

Accepted

You may be eligible if

Prostate sizing 80-150g
Ability to independently transfer and tolerate all 30min Emsella treatments (e.g. not wheelchair bound, no mobility issues)
Baseline M-ISI scores \<4
Same-day catheter removal and discharge
Able to read, understand, and complete surveys and questionnaires

You may not be if

Catheter dependence
Previous BPH procedure
Previous pelvic surgeries
Pre-existing pelvic floor dysfunction
Neurogenic bladder
Overactive bladder - e.g. prescribed and taking any oxybutynin or mirabegron
Preoperative pad-use for incontinence

The record

StatusNot yet recruiting

PhaseNo phase

Taking part30

StartedJun 2026

UpdatedMay 12, 2026

Conditions

Benign Prostatic Hyperplasia Enlarged Prostate With Lower Urinary Tract Symptoms Enlarged Prostate (BPH)

Where1

Northwestern University
Chicago, Illinois, United States

Clareo Health | Emsella for Reducing tSUI After HOLEP